Iron
Title
Date Published
Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.
October 16, 2012
Effect of different doses of iron supplementation during pregnancy on maternal and infant health.
October 4, 2012
Anaemia in hospital practice.
October 1, 2012
Comparative rates of adverse events with different formulations of intravenous iron.
September 11, 2012
Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
August 26, 2012
State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease.
August 20, 2012
Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia – systematic review and meta-analysis of randomised controlled trials.
August 9, 2012
Benefits of Iron supplementation for low birth weight infants: A systematic review.
July 16, 2012
Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*.
July 1, 2012
Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate.
June 29, 2012
Effect of iron supplementation on development of iron deficiency anemia in breastfed infants.
June 28, 2012
Iron therapy: Indications, limitations and modality. [Article in French]
May 21, 2012
Iron metabolism: State of the art. [Article in French]
May 15, 2012
A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation.
April 27, 2012
Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty.
March 1, 2012
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.
January 31, 2012
Iron deficiency syndromes and iron-restricted erythropoiesis.
December 29, 2011
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice.
December 12, 2011
Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective.
December 5, 2011
On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery.
November 30, 2011